Early ribavirin aerosol treatment of respiratory syncytial virus infection in high-risk children.

Ribavirin aerosols and respiratory syncytial virus infection.

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children.

Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats.

Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection.

Neonatal respiratory-syncytial-virus infection.

Neonatal respiratory syncytial virus infection.

Respiratory syncytial virus and the use of ribavirin.

Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Respiratory syncytial virus infection in inbred mice.

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Preventing hospitalizations for respiratory syncytial virus infection.

Respiratory syncytial virus infection and bronchiolitis.

Respiratory syncytial virus infection: an innate perspective.

Mechanical ventilation and respiratory syncytial virus infection.

Nosocomial infection with respiratory syncytial virus.

Host response to respiratory syncytial virus infection.

Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK.

The pathogenesis of respiratory syncytial virus infection in cotton rats.

Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol.

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.

The pathogenesis of respiratory syncytial virus infection in infant ferrets.

Lack of effect of respiratory syncytial virus infection on theophylline disposition in children.

Depletion of circulating regulatory T cells during severe respiratory syncytial virus infection in young children.

Suggest Documents

Ribavirin aerosols and respiratory syncytial virus infection.

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children.

Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats.

Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection.

Neonatal respiratory-syncytial-virus infection.

Neonatal respiratory syncytial virus infection.

Respiratory syncytial virus and the use of ribavirin.

Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Respiratory syncytial virus infection in inbred mice.

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Preventing hospitalizations for respiratory syncytial virus infection.

Respiratory syncytial virus infection and bronchiolitis.

Respiratory syncytial virus infection: an innate perspective.

Mechanical ventilation and respiratory syncytial virus infection.

Nosocomial infection with respiratory syncytial virus.

Host response to respiratory syncytial virus infection.

Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK.

The pathogenesis of respiratory syncytial virus infection in cotton rats.

Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol.

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.

The pathogenesis of respiratory syncytial virus infection in infant ferrets.

Lack of effect of respiratory syncytial virus infection on theophylline disposition in children.

Depletion of circulating regulatory T cells during severe respiratory syncytial virus infection in young children.

Early ribavirin aerosol treatment of respiratory syncytial virus infection in high-risk children.

Recommend Documents

Follow Us